APA (7th ed.) Citation

Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M. Abu-Serie, . . . Mohamed Teleb. (2023). New spiro-indeno[1,2-b]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Assem Barakat, et al. New Spiro-indeno[1,2-b]quinoxalines Clubbed with Benzimidazole Scaffold as CDK2 Inhibitors for Halting Non-small Cell Lung Cancer; Stereoselective Synthesis, Molecular Dynamics and Structural Insights. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Assem Barakat, et al. New Spiro-indeno[1,2-b]quinoxalines Clubbed with Benzimidazole Scaffold as CDK2 Inhibitors for Halting Non-small Cell Lung Cancer; Stereoselective Synthesis, Molecular Dynamics and Structural Insights. Taylor & Francis Group, 2023.